In the News
A multidisciplinary research team at Florida State University received a grant from the U.S. Health Resources and Services Administration (HRSA) to study the safety nets of low-income mothers and their families.
We are pleased to announce that Dr. Eugenia Millender received the prestigious invitation to speak at the White House! Dr. Millender has a storied history advocating for policies that promote health equity and access. Join us in congratulating Dr. Millender on this distinguished speaking engagement! #NoleNursesLead
A team of Florida State University researchers from the College of Nursing, College of Medicine and College of Arts & Sciences has received a $14.5 million National Institutes of Health grant to build a diverse community of early career researchers committed to improving mental health and chronic disease prevention and management.
Florida State University College of Nursing Research Series, Dr. Casey Xavier Hall presentation: Current Issues in Pre-exposure Prophylaxis for HIV Prevention.
Cocaine use disorder is a worldwide problem. Presently, however, no adequate treatments exist. Gabapentin has been explored recently as an alternative for treating different substance use disorders, including cocaine.
Congratulations to Associate Professor & Associate Director and Co-Founder of the Center for Population Sciences and Health Equity, Dr. Eugenia Millender, on being inducted into the latest Class of Fellows in the American Academy of Nursing (FAAN)!
GBH All Things Considered host Arun Rath spoke with BU professor Hyeouk Chris Hahm about the surge in racist incidents targeting Asian Americans. She's been looking at the toll racism, racist harassment and racist attacks have been taking on Asian Americans.
Bisexual women’s health and well-being may be affected by the gender and sexual orientation of their partner, according to a new study published in the Journal of Bisexuality.
Dr. Millender received the clinical research NIH Loan Repayment Program (LRPs) from the National Heart, Lung and Blood Institute (NHLBI) for two years (2020-2022).